Tirzepatide + Metabolic Health: What the Latest Study Really Shows | Solo EP. 207
Dr. Tyna Moore — Tirzepatide + Metabolic Health: What the Latest Study Really Shows | Solo EP. 207
Channel: Dr. Tyna Moore · Our label: Naturopathic clinician educator · Source: youtube.com/watch?v=DI8ZTp6fQPc
What this video covers
A recent study has come across my desk that I wanted to share with you. I was first alerted about it by some of the big obesity docs that I follow on social media and they came out and had one opinion about the paper. So, I looked up the paper immediately, of course, and found that you had to access it behind a payw wall and it was quite long. So, I went ahead and paid for the article so that I could read the whole thing because the title is a little misleading and the key highlights are a little bit misleading.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- First, they looked at preclinical mouse experiments and then they did a phase one clinical study on 55 humans.
- They stoke it, which is going to help with mitochondrial health, which is ultimately going to translate into metabolic health improvements.
- there’s a decrease inflammation of inflammation in the brain.
- Uh there’s various mechanisms by which GLP1s impart themselves on your metabolic health overall.
- But what sometimes actually happens, and they figured this out with a couple studies years back, most notably the Biggest Loser study.
- You’re either a prescribing doctor, you are a health professional that’s non-licensed, or you don’t have a prescribing license, or you’re the general population, general public.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.